TMCnet News
Research and Markets: Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And ForecastsDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/257bbj/diabetes_herbal) has announced the addition of the "Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs - Volume 1: Cinnamon Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side effect, which occurs due to the accumulation of glucose. This excess glucose is converted into various compounds and also into free radicals, which damage the vital organs and organelles. Diabetes was seriously underrated as a threat to global public health until very recently. Today, Diabetes now ranks as one of the greatest public health challenges in the history of mankind. According to this report, there were 382 million people with Diabetes, or 8.3% of the global population, in 2013. By 2035, this number will be 10.1%, equal almost 600 million people worldwide. Diabetes has a very large economic impact. For example, in the US the cost of diagnosed Diabetes in 2012 is estimated at US$245 billion, including $176 billion in direct medical costs. In 2013, the average Diabetes related expenditures per person in the US were USD9,800. Globally, per capita Diabetes related expenditures n 2013 were USD1,436. Further, the global market for Diabetes medications is estimated at approximately USD45 billion in 2013 and is growing 10.5% annually overall, with insulin sales increasing at a 14.2% CAGR. The currently available antidiabetic drugs manage the blood glucose levels under normal range by supplementing insulin, improving insulin sensitivity, increasing insulin secretion from the pancreas, decreasing glucose absorption from the intestinal tract and/or glucose uptake by tissue cells. Today, the management of Diabetes without any side effect is still a challenge to medical practitioners. However, a wide array of plant-derived active principles has demonstrated antidiabetic activity. These natural medicines modulate blood sugar levels through a variety of mechanisms. In some cases their effects are similar to conventional medicines. This report looks at the use of medicinal plants, rather than pharmaceutical drugs, to both prevent and treat Diabetes. Specifically, it looks in detail at one of these plants: Cinnamon. Cinnamon is widely used and available and the market for it is well developed. The modern literature shows that the potential antidiabetic properties of Cinnamon have been studied for over 20 years. Numerous trials have been conducted in humans to determine the metabolic effects of Cinnamon. A main mechanism of action of Cinnamon focuses on its ability to promote insulin signalling. The combined effects of Cinnamon are an increase in insulin sensitivity. It also increases the amount of insulin receptors thus enhancing cellular glucose uptake. Increased glycogen biosynthesis also has been observed, as well as the activation of transcription factors. Global production of Cinnamon is forecast to rise 15% annually in value, and 6% annually in volume, between 2014 and 2019. The report provides:
Additionally, profiles of 45 leading, public and private companies involved in the Cinnamon industry as producers, distributors, and retailers are given. For more information visit http://www.researchandmarkets.com/research/257bbj/diabetes_herbal About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products. |
